41 results
8-K
EX-99.1
INVA
Innoviva Inc
9 Apr 14
Regulation FD Disclosure
12:00am
of continuing VIBATIV® versus discontinuing and initiating therapy with an alternative agent should be assessed. Fetal Risk Women of childbearing … raise concerns about potential adverse developmental outcomes in humans. If not already pregnant, women of childbearing potential should use effective
8-K
EX-99
INVA
Innoviva Inc
6 Feb 14
Results of Operations and Financial Condition
12:00am
VIBATIV® versus discontinuing and initiating therapy with an alternative agent should be assessed.
Fetal Risk
Women of childbearing potential should have … potential adverse developmental outcomes in humans. If not already pregnant, women of childbearing potential should use effective contraception during
8-K
EX-99.1
INVA
Innoviva Inc
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
pregnancy, labour and in breastfeeding women should only occur if the potential benefit justifies the potential risk.
Drug interactions: Caution should
8-K
EX-99
aqb0pwci6 abvz71
21 Jun 13
Other Events
12:00am
8-K
EX-99
zeb5cnmgb2
25 Apr 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99
szda iqc5
12 Feb 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99
nvn7q2t x4
29 Nov 12
Regulation FD Disclosure
12:00am
8-K
EX-99
tuoj4l
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
bvh52pdmnhdbuesr9
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99
5nu6w
15 Sep 11
Other Events
12:00am
8-K
EX-99
vxyaq ujyrjwqsd6
20 May 11
Other Events
12:00am
8-K
EX-99.1
nkccowljska2jxlpy6mo
12 Jan 11
Regulation FD Disclosure
12:00am
8-K
EX-99.6
d8q48d3umuzvasgyz4g
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.5
9yr gl1si
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99
4xiejp uj7u9a4xp
21 Apr 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99
52625746
11 Feb 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99
aogligygeky3vz9k
28 Jan 10
Other Events
12:00am